Creative Biolabs, Neutralizing antibodies) Using NAbs to Fight the Novel Coronavirus?
작성자
abbabio
작성일자
2020-08-20
조회수
345
Developing countermeasures to prevent and treat COVID-19 continues to be a global health priority. Neutralizing antibodies (NAbs) to the causative agent of the disease, SARS-CoV-2, represent potential prophylactic and therapeutic options and could help guide vaccine design. NAb to another respiratory virus, RSV, has already been in clinical use to protect vulnerable infants prophylactically.
Creative Biolabs is a renowned leader in neutralizing antibody discovery and custom service, providing high-quality NAb products and expert services to analyze NAbs for customers in academia and industry worldwide.
During the past decade, thousands of NAbs have been isolated and expressed. These antibodies are now guiding the design of novel vaccine candidates for viral infection or used for biological therapeutics as large molecule drugs.
